Physician profile
Peter R Unkovic
NPI 1114269180
$19,331.38
in general payments reported to CMS, 2019-2025
20 companies · $490 in 2025
The $490 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $150 · 2021: $266 · 2022: $668 · 2023: $1,664 · 2024: $793 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101 · Travel and Lodging: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,101.41 |
| Travel and Lodging | $845.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $15,079.95 | 2019-2020 | |
| Boston Scientific Corporation | $1,644.98 | 2021-2025 | Resonate El Icd Vr, General - Therapies, Vigilant X4 Crt-D |
| Amgen INC. | $428.60 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $419.43 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $348.73 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $326.63 | 2019-2024 | Farxiga |
| Abbott Laboratories | $276.70 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $249.96 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $123.91 | 2019-2022 | |
| Medtronic, INC. | $123.67 | 2022-2024 | Reveal Linq, Symplicity G3 |
| Merck Sharp & Dohme LLC | $98.19 | 2025 | Winrevair |
| Alnylam Pharmaceuticals INC. | $42.44 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $36.94 | 2024 | Camzyos |
| Cardinal Health 200 LLC | $35.29 | 2019 | |
| Novo Nordisk INC | $19.69 | 2023 | Ozempic |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $18.83 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.74 | 2022 | |
| Esperion Therapeutics, INC. | $14.75 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.68 | 2020 | |
| Cardiac Dimensions, INC. | $10.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Unkovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.